Search filters

List of works by M Ferrante

Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response.

scientific article

Dose de-escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease - a nested case-control study.

scientific article

Editorial: a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era-getting nearer?

scientific article published on 01 April 2020

Editorial: biomarker predictors of non-response to TNFα antagonists - the quest continues. Authors' reply

scientific article published on 01 April 2019

Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells

scientific article published on 21 June 2020

Influence of early adalimumab serum levels on immunogenicity and long-term outcome of anti-TNF naive Crohn's disease patients: the usefulness of rapid testing

scientific article published on 15 August 2018

Molecular Changes in the Non-Inflamed Terminal Ileum of Patients with Ulcerative Colitis

scientific article published on 28 July 2020

Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease

scientific article published on 20 January 2019

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study

scientific article published on 06 November 2019

Thiopurine monotherapy has a limited place in treatment of patients with mild-to-moderate Crohn's disease

scientific article published on 14 September 2020

When IBD is not IBD

scientific article published on 26 September 2018

Paulina is supported by:

About Paulina

Help